Trade and Deputy Prime Minister of Singapore, Gan Kim Yong, revealed that Singapore is currently negotiating concessions for its pharmaceutical exports to the U.S. while ensuring continued access to high-end AI chips from the American market. This strategic move aims to balance economic interests and technological advancement between the two nations.